Metastatic Bone Disease, also known as secondary Bone Cancer, occurs when cancer cells from a primary tumor elsewhere in the body spread (metastasize) to the bones. This condition is more common than primary Bone Cancer. Cancer cells typically travel through the bloodstream or lymphatic system, reaching bones and forming new tumors. The most frequent sources of metastasis to the bones include breast, lung, prostate, and kidney cancers. Metastatic bone disease often leads to weakened bones, causing pain, fractures, and other complications. Diagnostic tools like imaging studies and biopsies help identify the presence of metastases and determine the best course of treatment. Management involves a multidisciplinary approach, including systemic therapies such as chemotherapy, hormone therapy, or targeted therapies, along with localized interventions like radiation therapy or surgery to address specific bone lesions. While metastatic bone disease is challenging, advancements in cancer treatments and supportive care have improved outcomes and quality of life for individuals facing this condition. Early detection and a comprehensive treatment plan tailored to the patient's unique circumstances are crucial in managing metastatic bone disease effectively.
Title : Update on orthopedic-implant-cobaltism
Stephen S Tower, University of Alaska Anchorage, United States
Title : Acute traumatic spinal injuries - Outcomes based evidence of the holistic active physiological conservative management of the injury and its neurological effects
Wagih El Masri, Keele University, United Kingdom
Title : Why rehabilitation following Total Joint Arthroplasty (TJA) should include a gait kinematic assessment and gait retraining
Diana Hodgins, Dynamic Metrics Ltd, United Kingdom
Title : Clinical characteristics and one-year outcomes of lateral ankle sprains in young active adults referred for rehabilitation
Dib Kheir Eddine, Regional University Military Hospital of Oran, Algeria
Title : Modifiable lifestyle and occupational risk factors associated with dupuytrens disease: A systematic review and meta analysis
Mohammed Jameel, East Lancashire Hospitals Trust, United Kingdom
Title : The tomographic phenotype and the genotype of wormian bones
Ali Al Kaissi, National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation